96 related articles for article (PubMed ID: 26338485)
1. 18F-FDG PET/CT Prediction of an Aggressive Clinical Course for Dermatofibrosarcoma Protuberans.
Basu S; Goliwale F
J Nucl Med Technol; 2016 Jun; 44(2):88-9. PubMed ID: 26338485
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in Dermatofibrosarcoma Protuberans.
Wu J; Zhang S; Rao Z; Wang Y; Zhang C
Clin Nucl Med; 2022 Jul; 47(7):629-631. PubMed ID: 35452009
[TBL] [Abstract][Full Text] [Related]
3. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.
Rubin BP; Schuetze SM; Eary JF; Norwood TH; Mirza S; Conrad EU; Bruckner JD
J Clin Oncol; 2002 Sep; 20(17):3586-91. PubMed ID: 12202658
[TBL] [Abstract][Full Text] [Related]
4. Recurrent dermatofibrosarcoma protuberans with pulmonary metastases presenting twelve years after initial diagnosis: 18F-FDG PET/CT imaging findings.
Suman S; Sharma P; Jain TK; Sahoo MK; Bal C; Kumar R
Clin Nucl Med; 2014 Jan; 39(1):77-8. PubMed ID: 23531730
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT in a seldom case of primary duodenal dermatofibrosarcoma protuberans with lung and skeletal metastases.
Karunanithi S; Jain TK; Singh A; Bal C; Kumar R
Clin Nucl Med; 2015 Feb; 40(2):e140-2. PubMed ID: 24999683
[TBL] [Abstract][Full Text] [Related]
6. Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp.
Kasper B; Lossignol D; Gil T; Flamen P; De Saint Aubain N; Awada A
Anticancer Drugs; 2006 Nov; 17(10):1223-5. PubMed ID: 17075323
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of dermatofibrosarcoma protuberans in post-surgical scar detected by 18F-FDG-PET imaging.
Basu S; Baghel NS
Hell J Nucl Med; 2009; 12(1):68. PubMed ID: 19330190
[No Abstract] [Full Text] [Related]
8. Increased 68 Ga-FAPI Uptake in Dermatofibrosarcoma Protuberans.
Yang X; Chen H; Li M; Chen Y; Liu H
Clin Nucl Med; 2022 Aug; 47(8):710-711. PubMed ID: 35605047
[TBL] [Abstract][Full Text] [Related]
9. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
Gayed I; Vu T; Iyer R; Johnson M; Macapinlac H; Swanston N; Podoloff D
J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
[TBL] [Abstract][Full Text] [Related]
10. Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate.
Labropoulos SV; Fletcher JA; Oliveira AM; Papadopoulos S; Razis ED
Anticancer Drugs; 2005 Apr; 16(4):461-6. PubMed ID: 15746584
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up.
Ugurel S; Mentzel T; Utikal J; Helmbold P; Mohr P; Pföhler C; Schiller M; Hauschild A; Hein R; Kämpgen E; Kellner I; Leverkus M; Becker JC; Ströbel P; Schadendorf D
Clin Cancer Res; 2014 Jan; 20(2):499-510. PubMed ID: 24173542
[TBL] [Abstract][Full Text] [Related]
12. Dermatofibrosarcoma protuberans - the use of neoadjuvant imatinib for treatment of an uncommon breast malignancy: a case report.
McGee MW; Boukhar SA; Monga V; Weigel R; Phadke SD
J Med Case Rep; 2019 Dec; 13(1):374. PubMed ID: 31852518
[TBL] [Abstract][Full Text] [Related]
13. Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
De Luca S; Fonti R; Camera L; Salvatore B; Faggiano A; Ciarmiello A; Segreto S; Colao A; Salvatore M; Del Vecchio S
Ann Nucl Med; 2016 Apr; 30(3):234-41. PubMed ID: 26753628
[TBL] [Abstract][Full Text] [Related]
14. Computed tomographic and pathological findings of dermatofibrosarcoma protuberans.
Li X; Zhang W; Xiao L; Zeng Q; Wu X; Qin J; Shen Y
J Comput Assist Tomogr; 2012; 36(4):462-8. PubMed ID: 22805678
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
[TBL] [Abstract][Full Text] [Related]
16. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
[TBL] [Abstract][Full Text] [Related]
17. Imaging Features of Breast Dermatofibrosarcoma Protuberans in Various Modalities Including FDG-PET CT.
Bae SH; Lee JY
Iran J Radiol; 2016 Apr; 13(2):e33916. PubMed ID: 27703659
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in dermatofibrosarcoma protuberans on treatment with imatinib.
Kashyap R; Muddu VK; Anantamakula S; Sri S
Indian J Nucl Med; 2016; 31(3):191-3. PubMed ID: 27385888
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study.
Shmidt E; Nehra V; Lowe V; Oxentenko AS
BMC Gastroenterol; 2016 Oct; 16(1):125. PubMed ID: 27716085
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
